GlassScriptPhysician profile
William Herman Sessions
NPI 1669471033
$5,413.44
in general payments reported to CMS, 2019-2025
41 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,583 · 2020: $596 · 2021: $525 · 2022: $717 · 2023: $1,325 · 2024: $187 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $993.57 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $665.55 | 2019-2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $502.09 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Astellas Pharma US INC | $382.52 | 2019-2023 | Myrbetriq |
| Amgen INC. | $369.27 | 2019-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $294.63 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $292.01 | 2019-2023 | Gardasil 9, Vaxneuvance |
| Novartis Pharmaceuticals Corporation | $214.14 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $168.51 | 2023-2025 | Rexulti |
| Lilly USA, LLC | $110.73 | 2019-2025 | Jardiance, Kisunla |
| Exact Sciences Corporation | $105.97 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $94.47 | 2021-2023 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $93.91 | 2019-2023 | |
| Lundbeck LLC | $93.16 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $93.06 | 2022-2023 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sessions listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.